Safety and Usability of the Inga Catheter for Labor Induction (INGA-MDP)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-56
SponsorAalto University

About this trial

The goal of this clinical study is to evaluate a new mechanical balloon catheter (INGA) used to prepare the cervix for labor induction in pregnant women at term.

The study aims to assess the safety, usability, and performance of the INGA catheter when used for cervical ripening before labor. Researchers will also collect feedback from healthcare professionals and participants about the use of the device.

Participants are pregnant women at term with a single baby in a head-down position who meet the study eligibility criteria.

Participants will:

* have the INGA balloon catheter inserted as part of labor induction, * receive standard clinical care according to hospital practice, * provide information about their experience and outcomes related to the device.

The results of this study will help determine whether the INGA catheter is safe and suitable for use in cervical ripening during labor induction.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women aged ≥18 and ≤56 years

An unripe cervix, ≤6 points according to the Bishop assessment (0-10 point scale)

Planned induction of labor by mechanical balloon catheter method

Post-term pregnancy (≥41 weeks of gestation)

Disqualifiers

Preterm induction of labor (<37 weeks of gestation)

Pathological CTG at inclusion

Spontaneous rupture of membranes at inclusion

Clinically significant vaginal bleeding with need of hospitalization in the third trimester

Trial design

Design model

Single group

Treatments tested in this trial

  • Cervical ripening, labor induction

    Device

    This study uses the INGA cervical ripening balloon catheter for labor induction, with standardized insertion and saline filling according to device instructions, allowing the balloon to remain in place up to 24 hours. The trial systematically collects data on catheter usability, insertion experience, patient pain, retention time, and delivery outcomes, as well as feedback from both participants and healthcare professionals regarding device performance and usability. Cervical status is evaluated using the Bishop score before and after catheter use.

Treatment groups

45 Participants
are divided into 1 treatment group
Group A: INGA catheter for cervical ripeningExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Bishop score

The change in Bishop score (on a scale from 0 to 10) during cervical ripening assessed prior to catheter insertion and after catheter detachment

Time frame
From catheter insertion to detachment

Secondary outcomes

1

Successful catheter placement (clinical assessment by investigator)

Successful placement defined as correct intrauterine positioning of the catheter as confirmed clinically by the inserting healthcare professional at the time of insertion.

Time frame
Periprocedural (at the time of catheter insertion)
2

Retention time of the balloon catheter

Duration (in hours) that the balloon catheter remains in place in the cervix for cervical ripening.

Time frame
From balloon catheter placement to catheter detachment (up to 24 hours)
3

Induction to delivery interval

Time (in hours) from initiation of labor induction (balloon catheter insertion) to delivery of the neonate. This includes both the cervical ripening phase and active labor.

Time frame
From balloon catheter insertion to delivery of the neonate (assessed up to 48 hours after induction initiation)
4

Mode of delivery

The type of delivery for the participant, categorized as vaginal delivery, instrumental vaginal delivery, or cesarean section.

Time frame
From enrolment to birth

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Aalto University

Lead sponsor

Tampere University Hospital

Collaborator

Jyväskylä Central Hospital

Collaborator

Helsinki University Central Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: